Currently, there are 394.44M common shares owned by the public and among those 376.28M shares have been available to trade.
The company’s stock has a 5-day price change of 13.07% and -5.82% over the past three months. CLOV shares are trading 18.10% year to date (YTD), with the 12-month market performance up to 286.01% higher. It has a 12-month low price of $0.61 and touched a high of $4.71 over the same period. CLOV has an average intraday trading volume of 6.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 13.10%, 8.72%, and 62.54% respectively.
Institutional ownership of Clover Health Investments Corp (NASDAQ: CLOV) shares accounts for 16.44% of the company’s 394.44M shares outstanding.
It has a market capitalization of $1.86B and a beta (3y monthly) value of 1.92. The earnings-per-share (ttm) stands at -$0.19. The company has a debt-to-equity ratio at 0.01. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.27% over the week and 5.69% over the month.
Earnings per share for the fiscal year are expected to increase by 73.20%, and -16.51% over the next financial year.
Looking at the support for the CLOV, a number of firms have released research notes about the stock. Craig Hallum stated their Buy rating for the stock in a research note on December 17, 2024, with the firm’s price target at $6. UBS coverage for the Clover Health Investments Corp (CLOV) stock in a research note released on October 07, 2024 offered a Neutral rating with a price target of $4. Cowen was of a view on February 02, 2022 that the stock is Market Perform, while Canaccord Genuity gave the stock Buy rating on February 02, 2022, issuing a price target of $6. SVB Leerink on their part issued Mkt Perform rating on January 19, 2022.
